69 related articles for article (PubMed ID: 12800081)
1. [Expression of members of the cadherin-/catenin-protein family in juvenile angiofibromas].
Rippel C; Plinkert PK; Schick B
Laryngorhinootologie; 2003 May; 82(5):353-7. PubMed ID: 12800081
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of E-cadherin, beta-catenin and gamma-catenin gene expression with the invasion and metastasis of gastric carcinoma].
Wang CX; Chen J; Yang Z; Song W; Du ZL; Li ZH
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1198-201. PubMed ID: 14625188
[TBL] [Abstract][Full Text] [Related]
3. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
4. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
El-Bahrawy MA; Talbot IC; Poulsom R; Jeffery R; Alison MR
J Pathol; 2002 Sep; 198(1):69-76. PubMed ID: 12210065
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
[TBL] [Abstract][Full Text] [Related]
6. Plakoglobin induces desmosome formation and epidermoid phenotype in N-cadherin-expressing squamous carcinoma cells deficient in plakoglobin and E-cadherin.
Parker HR; Li Z; Sheinin H; Lauzon G; Pasdar M
Cell Motil Cytoskeleton; 1998; 40(1):87-100. PubMed ID: 9605974
[TBL] [Abstract][Full Text] [Related]
7. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
[TBL] [Abstract][Full Text] [Related]
8. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
9. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
[TBL] [Abstract][Full Text] [Related]
10. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
[TBL] [Abstract][Full Text] [Related]
14. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
15. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
[TBL] [Abstract][Full Text] [Related]
17. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas.
Abraham SC; Montgomery EA; Giardiello FM; Wu TT
Am J Pathol; 2001 Mar; 158(3):1073-8. PubMed ID: 11238055
[TBL] [Abstract][Full Text] [Related]
18. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T
J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
20. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]